Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
To compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and are seeking first chemotherapy treatment
Colorectal Neoplasms|Colonic Neoplasms|Rectal Neoplasms
DRUG: Vatalanib
Progression free survival, Throughout duration of study
Time to progression, Throughout duration of study|Time to treatment failure, Throughout duration of study|Best overall response rate, Throughout duration of study|Tolerability and safety profile, Throughout duration of study
To compare treatment with oxaliplatin/5-FU/leucovorin plus vatalanib versus oxaliplatin/5-FU/leucovorin plus placebo in patients with colorectal cancer that has spread to other organs and are seeking first chemotherapy treatment